Channelpedia

Cav3.2 Channel

316 automatically matched literature references

1

Berecki G et al. Mechanism of direct Cav2.2 channel block by the κ-opioid receptor agonist U50488H.
Neuropharmacology, 2016 May 28 , 109 (49-58).

4

Yang W et al. Cannabinoid receptor agonists modulate calcium channels in rat retinal müller cells.
Neuroscience, 2016 Jan 28 , 313 (213-24).

9

Butler MG et al. Currently recognized genes for schizophrenia: High-resolution chromosome ideogram representation.
Am. J. Med. Genet. B Neuropsychiatr. Genet., 2015 Oct 13 , ().

11

Park SJ et al. Differential zinc permeation and blockade of L-type Ca2+ channel isoforms Cav1.2 and Cav1.3.
Biochim. Biophys. Acta, 2015 Oct , 1848 (2092-100).

12

Siapich SA et al. Low concentrations of ethanol but not of dimethyl sulfoxide (DMSO) impair reciprocal retinal signal transduction.
Graefes Arch. Clin. Exp. Ophthalmol., 2015 Oct , 253 (1713-9).

13

Blesneac I et al. Phosphorylation of the Cav3.2 T-type calcium channel directly regulates its gating properties.
Proc. Natl. Acad. Sci. U.S.A., 2015 Nov 3 , 112 (13705-10).

14

Harraz OF et al. CaV1.2/CaV3.x channels mediate divergent vasomotor responses in human cerebral arteries.
J. Gen. Physiol., 2015 May , 145 (405-18).

19

Monteil A et al. Inhibition of Cav3.2 T-type Calcium Channels by Its Intracellular I-II Loop.
J. Biol. Chem., 2015 Jun 26 , 290 (16168-76).

20

Elíes J et al. H2S does not regulate proliferation via T-type Ca2+ channels.
Biochem. Biophys. Res. Commun., 2015 Jun 12 , 461 (659-64).

21

Tompkins JD et al. Nickel suppresses the PACAP-induced increase in guinea pig cardiac neuron excitability.
Am. J. Physiol., Cell Physiol., 2015 Jun 1 , 308 (C857-66).

26

Makarenko VV et al. CaV3.2 T-type Ca²⁺ channels in H₂S-mediated hypoxic response of the carotid body.
Am. J. Physiol., Cell Physiol., 2015 Jan 15 , 308 (C146-54).

28

30

Hamby AM et al. CaV3.2 KO mice have altered retinal waves but normal direction selectivity.
Vis. Neurosci., 2015 Jan , 32 (E003).

32

34

Weaver EM et al. Regulation of T-type calcium channel expression by sodium butyrate in prostate cancer cells.
Eur. J. Pharmacol., 2015 Feb 15 , 749 (20-31).

35

Männikkö R et al. Pharmacological and electrophysiological characterisation of hERG activator AZSMO-23.
Br. J. Pharmacol., 2015 Feb 12 , ().

39

Murakami-Nakayama M et al. Polaprezinc attenuates cyclophosphamide-induced cystitis and related bladder pain in mice.
J. Pharmacol. Sci., 2015 Feb , 127 (223-8).

41

Harraz OF et al. Genetic ablation of CaV3.2 channels enhances the arterial myogenic response by modulating the RyR-BKCa axis.
Arterioscler. Thromb. Vasc. Biol., 2015 Aug , 35 (1843-51).

43

Fukami K et al. Hydrogen sulfide and neuronal differentiation: focus on Ca2+ channels.
Nitric Oxide, 2015 Apr 30 , 46 (50-4).

46

Elíes J et al. Inhibition of T-type Ca(2+) Channels by Hydrogen Sulfide.
Adv. Exp. Med. Biol., 2015 , 860 (353-60).

49

61

Harraz OF et al. Ca(V)3.2 channels and the induction of negative feedback in cerebral arteries.
Circ. Res., 2014 Sep 12 , 115 (650-61).

62

Chevalier M et al. T-type calcium channels are involved in hypoxic pulmonary hypertension.
Cardiovasc. Res., 2014 Sep 1 , 103 (597-606).

66

Felizola SJ et al. Voltage-gated calcium channels in the human adrenal and primary aldosteronism.
J. Steroid Biochem. Mol. Biol., 2014 Oct , 144 Pt B (410-6).

70

Lin SS et al. Cav3.2 T-type calcium channel is required for the NFAT-dependent Sox9 expression in tracheal cartilage.
Proc. Natl. Acad. Sci. U.S.A., 2014 May 13 , 111 (E1990-8).

71

González-Ramírez R et al. Transcription factor Sp1 regulates T-type Ca(2+) channel CaV 3.1 gene expression.
J. Cell. Physiol., 2014 May , 229 (551-60).

72

Perissinotti PP et al. Down-regulation of endogenous KLHL1 decreases voltage-gated calcium current density.
Cell Calcium, 2014 May , 55 (269-80).

76

Alday A et al. Ionic channels underlying the ventricular action potential in zebrafish embryo.
Pharmacol. Res., 2014 Jun , 84 (26-31).

77

Tektürk P et al. Calcium channel antibodies in patients with absence epilepsy.
Int. J. Neurosci., 2014 Jul , 124 (486-90).

81

Sekiguchi F et al. Endogenous and exogenous hydrogen sulfide facilitates T-type calcium channel currents in Cav3.2-expressing HEK293 cells.
Biochem. Biophys. Res. Commun., 2014 Feb 28 , 445 (225-9).

82

Eckle VS et al. Mechanisms by which a CACNA1H mutation in epilepsy patients increases seizure susceptibility.
J. Physiol. (Lond.), 2014 Feb 15 , 592 (795-809).

83

Michaela P et al. Bisphenol A differently inhibits CaV3.1, Ca V3.2 and Ca V3.3 calcium channels.
Naunyn Schmiedebergs Arch. Pharmacol., 2014 Feb , 387 (153-63).

85

Elíes J et al. Hydrogen sulfide inhibits Cav3.2 T-type Ca2+ channels.
FASEB J., 2014 Dec , 28 (5376-87).

87

Lee SE et al. Rebound burst firing in the reticular thalamus is not essential for pharmacological absence seizures in mice.
Proc. Natl. Acad. Sci. U.S.A., 2014 Aug 12 , 111 (11828-33).

89

Zheng H et al. Expression and function of a T-type Ca2+ conductance in interstitial cells of Cajal of the murine small intestine.
Am. J. Physiol., Cell Physiol., 2014 Apr 1 , 306 (C705-13).

90

Carbone E et al. T-type channel-mediated neurotransmitter release.
Pflugers Arch., 2014 Apr , 466 (677-87).

91

Kuo IY et al. Role of T-type channels in vasomotor function: team player or chameleon?
Pflugers Arch., 2014 Apr , 466 (767-79).

92

Chemin J et al. Modulation of T-type calcium channels by bioactive lipids.
Pflugers Arch., 2014 Apr , 466 (689-700).

94

Shuba YM Models of calcium permeation through T-type channels.
Pflugers Arch., 2014 Apr , 466 (635-44).

95

Perez-Reyes E et al. Ins and outs of T-channel structure function.
Pflugers Arch., 2014 Apr , 466 (627-33).

97

Bladen C et al. Block of T-type calcium channels by protoxins I and II.
Mol Brain, 2014 , 7 (36).

102

Elies J et al. OP20 Inhibition of recombinant T-type Ca(2+) channels by hydrogen sulfide.
Nitric Oxide, 2013 Sep 1 , 31 Suppl 2 (S27-8).

106

Demers-Giroux PO et al. Cooperative activation of the T-type CaV3.2 channel: interaction between Domains II and III.
J. Biol. Chem., 2013 Oct 11 , 288 (29281-93).

108

109

111

Seo H et al. Effects of eugenol on T-type Ca2+ channel isoforms.
J. Pharmacol. Exp. Ther., 2013 Nov , 347 (310-7).

115

Nosal OV et al. Complex modulation of Ca(v)3.1 T-type calcium channel by nickel.
Cell. Mol. Life Sci., 2013 May , 70 (1653-61).

121

Engbers JD et al. Modeling interactions between voltage-gated Ca ( 2+) channels and KCa1.1 channels.
Channels (Austin), 2013 Jul 31 , 7 ().

122

Harraz OF et al. Protein kinase A regulation of T-type Ca2+ channels in rat cerebral arterial smooth muscle.
J. Cell. Sci., 2013 Jul 1 , 126 (2944-54).

124

Zhang Y et al. Modulation of low-voltage-activated T-type Ca²⁺ channels.
Biochim. Biophys. Acta, 2013 Jul , 1828 (1550-9).

125

Todorovic SM et al. Neuropathic pain: role for presynaptic T-type channels in nociceptive signaling.
Pflugers Arch., 2013 Jul , 465 (921-7).

127

Abd El-Rahman RR et al. Identification of L- and T-type Ca2+ channels in rat cerebral arteries: role in myogenic tone development.
Am. J. Physiol. Heart Circ. Physiol., 2013 Jan 1 , 304 (H58-71).

131

Shan HQ et al. Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C.
Alcohol. Clin. Exp. Res., 2013 Aug , 37 (1333-42).

135

Sekiguchi F et al. T-type calcium channels: functional regulation and implication in pain signaling.
J. Pharmacol. Sci., 2013 , 122 (244-50).

138

139

Bladen C et al. Common mechanisms of drug interactions with sodium and T-type calcium channels.
Mol. Pharmacol., 2012 Sep , 82 (481-7).

140

Lopez-Charcas O et al. Block of human CaV3 channels by the diuretic amiloride.
Mol. Pharmacol., 2012 Oct , 82 (658-67).

146

Balderas E et al. Niflumic acid blocks native and recombinant T-type channels.
J. Cell. Physiol., 2012 Jun , 227 (2542-55).

147

Gönczi M et al. Age-dependent changes in ion channel mRNA expression in canine cardiac tissues.
Gen. Physiol. Biophys., 2012 Jun , 31 (153-62).

149

150

156

Bolaños-Jiménez R et al. Mice mechanoreceptors are modulated by Ca(v)3.2 T-type calcium channels.
J. Physiol. (Lond.), 2012 Jan 1 , 590 (7).

159

Schweikart K et al. The effects of jaspamide on human cardiomyocyte function and cardiac ion channel activity.
Toxicol In Vitro, 2012 Dec 20 , 27 (745-751).

175

Wang R et al. The Cav3.2 T-type calcium channel regulates temporal coding in mouse mechanoreceptors.
J. Physiol. (Lond.), 2011 May 1 , 589 (2229-43).

177

Marger F et al. T-type calcium channels contribute to colonic hypersensitivity in a rat model of irritable bowel syndrome.
Proc. Natl. Acad. Sci. U.S.A., 2011 Jul 5 , 108 (11268-73).

180

Poulsen CB et al. T-type voltage-gated calcium channels regulate the tone of mouse efferent arterioles.
Kidney Int., 2011 Feb , 79 (443-51).

183

Liu G et al. [Regulation of T-type Ca(2+) channel in lysophosphatidylcholine-stimulated cardiomyocytes].
Beijing Da Xue Xue Bao, 2011 Dec 18 , 43 (804-8).

184

Lacinová L T-type calcium channel blockers - new and notable.
Gen. Physiol. Biophys., 2011 Dec , 30 (403-9).

185

Astori S et al. The Ca(V)3.3 calcium channel is the major sleep spindle pacemaker in thalamus.
Proc. Natl. Acad. Sci. U.S.A., 2011 Aug 16 , 108 (13823-8).

193

Cribbs L T-type calcium channel expression and function in the diseased heart.
Channels (Austin), 2010 Nov-Dec , 4 (447-52).

194

Cain SM et al. Contributions of T-type calcium channel isoforms to neuronal firing.
Channels (Austin), 2010 Nov-Dec , 4 (475-82).

195

Perez-Reyes E Characterization of the gating brake in the I-II loop of CaV3 T-type calcium channels.
Channels (Austin), 2010 Nov-Dec , 4 (453-8).

196

Anderson D et al. Regulation of the KV4.2 complex by CaV3.1 calcium channels.
Channels (Austin), 2010 May-Jun , 4 (163-7).

201

Strege PR et al. T-type Ca(2+) channel modulation by otilonium bromide.
Am. J. Physiol. Gastrointest. Liver Physiol., 2010 May , 298 (G706-13).

203

Liu H et al. ACTH induces Cav3.2 current and mRNA by cAMP-dependent and cAMP-independent mechanisms.
J. Biol. Chem., 2010 Jun 25 , 285 (20040-50).

204

Aromolaran KA et al. T-type current modulation by the actin-binding protein Kelch-like 1.
Am. J. Physiol., Cell Physiol., 2010 Jun , 298 (C1353-62).

205

Kuo IY et al. Dihydropyridine-insensitive calcium currents contribute to function of small cerebral arteries.
J. Cereb. Blood Flow Metab., 2010 Jun , 30 (1226-39).

211

Ono K et al. Cardiac T-type Ca(2+) channels in the heart.
J. Mol. Cell. Cardiol., 2010 Jan , 48 (65-70).

212

You H et al. CCR2 receptor ligands inhibit Cav3.2 T-type calcium channels.
Mol. Pharmacol., 2010 Feb , 77 (211-7).

213

Perez-Reyes E G protein-mediated inhibition of Cav3.2 T-type channels revisited.
Mol. Pharmacol., 2010 Feb , 77 (136-8).

218

Liang H et al. Electrophysiological basis of the first heart beats.
Cell. Physiol. Biochem., 2010 , 25 (561-70).

221

232

Jensen LJ et al. Is there a role for T-type Ca2+ channels in regulation of vasomotor tone in mesenteric arterioles?
Can. J. Physiol. Pharmacol., 2009 Jan , 87 (8-20).

237

Zamponi GW et al. Role of voltage-gated calcium channels in epilepsy.
, 2009 Dec 20 , ().

240

Mulgrew CJ et al. Inhibition of human mesangial cell proliferation by targeting T-type calcium channels.
Nephron Exp. Nephrol., 2009 , 113 (e77-88).

245

Huh SU et al. Regulation of CA(v)3.2 Ca2+ channel activity by protein tyrosine phosphorylation.
J. Microbiol. Biotechnol., 2008 Feb , 18 (365-8).

254

Traboulsie A et al. Subunit-specific modulation of T-type calcium channels by zinc.
J. Physiol. (Lond.), 2007 Jan 1 , 578 (159-71).

258

Sun HS et al. Zn2+ sensitivity of high- and low-voltage activated calcium channels.
Biophys. J., 2007 Aug 15 , 93 (1175-83).

259

260

Nordskog BK et al. Diurnal gene expression patterns of T-type calcium channels and their modulation by ethanol.
Neuroscience, 2006 Sep 1 , 141 (1365-73).

261

Mathie A et al. Zinc and copper: pharmacological probes and endogenous modulators of neuronal excitability.
Pharmacol. Ther., 2006 Sep , 111 (567-83).

262

Liang J et al. New variants in the CACNA1H gene identified in childhood absence epilepsy.
Neurosci. Lett., 2006 Oct 2 , 406 (27-32).

266

Chioza B et al. Evaluation of CACNA1H in European patients with childhood absence epilepsy.
Epilepsy Res., 2006 May , 69 (177-81).

271

Kim JA et al. Augmentation of Cav3.2 T-type calcium channel activity by cAMP-dependent protein kinase A.
J. Pharmacol. Exp. Ther., 2006 Jul , 318 (230-7).

272

Kang HW et al. A molecular determinant of nickel inhibition in Cav3.2 T-type calcium channels.
J. Biol. Chem., 2006 Feb 24 , 281 (4823-30).

276

Perez-Reyes E et al. Molecular biology of T-type calcium channels.
CNS Neurol Disord Drug Targets, 2006 Dec , 5 (605-9).

277

Lambert RC et al. Modulation of neuronal T-type calcium channels.
CNS Neurol Disord Drug Targets, 2006 Dec , 5 (611-27).

278

Splawski I et al. CACNA1H mutations in autism spectrum disorders.
J. Biol. Chem., 2006 Aug 4 , 281 (22085-91).

279

Perez-Reyes E Molecular characterization of T-type calcium channels.
Cell Calcium, 2006 Aug , 40 (89-96).

280

Talavera K et al. Biophysics and structure-function relationship of T-type Ca2+ channels.
Cell Calcium, 2006 Aug , 40 (97-114).

281

Lory P et al. T-type calcium channels in differentiation and proliferation.
Cell Calcium, 2006 Aug , 40 (135-46).

283

Wang JL et al. [The effect of CACNA1H gene G773D mutation on calcium channel function]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2006 Aug , 23 (369-73).

285

Mulley JC et al. Susceptibility genes for complex epilepsy.
Hum. Mol. Genet., 2005 Oct 15 , 14 Spec No. 2 (R243-9).

289

Khosravani H et al. Effects of Cav3.2 channel mutations linked to idiopathic generalized epilepsy.
Ann. Neurol., 2005 May , 57 (745-9).

293

Brueggemann LI et al. Low voltage-activated calcium channels in vascular smooth muscle: T-type channels and AVP-stimulated calcium spiking.
Am. J. Physiol. Heart Circ. Physiol., 2005 Feb , 288 (H923-35).

294

296

Gardiner M Genetics of idiopathic generalized epilepsies.
Epilepsia, 2005 , 46 Suppl 9 (15-20).

298

Niwa N et al. Cav3.2 subunit underlies the functional T-type Ca2+ channel in murine hearts during the embryonic period.
Am. J. Physiol. Heart Circ. Physiol., 2004 Jun , 286 (H2257-63).

302

Heron SE et al. Genetic variation of CACNA1H in idiopathic generalized epilepsy.
Ann. Neurol., 2004 Apr , 55 (595-6).

304

Delisle BP et al. Monovalent cations contribute to T-type calcium channel (Cav3.1 and Cav3.2) selectivity.
J. Membr. Biol., 2003 Jun 1 , 193 (185-94).

306

Perez-Reyes E Molecular physiology of low-voltage-activated t-type calcium channels.
Physiol. Rev., 2003 Jan , 83 (117-61).

307

308

Yunker AM et al. Low-voltage-activated ("T-Type") calcium channels in review.
J. Bioenerg. Biomembr., 2003 Dec , 35 (533-75).

309

Chen Y et al. Association between genetic variation of CACNA1H and childhood absence epilepsy.
Ann. Neurol., 2003 Aug , 54 (239-43).

314

Kushmerick C et al. Changes in Ca(2+) channel expression upon differentiation of SN56 cholinergic cells.
Brain Res., 2001 Oct 19 , 916 (199-210).

315

Perez-Reyes E et al. Molecular characterization of two members of the T-type calcium channel family.
Ann. N. Y. Acad. Sci., 1999 Apr 30 , 868 (131-43).